Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MSTR NASDAQ:SMLR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMSTRStrategy$92.10-2.7%$133.09$81.81▼$457.22$33.17B3.5425.70 million shs12.61 million shsSMLRSemler Scientific$20.33-4.9%$19.24$14.89▼$50.44$310.74M1.32895,814 shs1.62 million shsThe 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMSTRStrategy0.00%-6.08%-23.66%-28.50%-78.22%SMLRSemler Scientific0.00%0.00%0.00%0.00%-55.35%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMSTRStrategy$92.10-2.7%$133.09$81.81▼$457.22$33.17B3.5425.70 million shs12.61 million shsSMLRSemler Scientific$20.33-4.9%$19.24$14.89▼$50.44$310.74M1.32895,814 shs1.62 million shsThe 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMSTRStrategy0.00%-6.08%-23.66%-28.50%-78.22%SMLRSemler Scientific0.00%0.00%0.00%0.00%-55.35%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMSTRStrategy 2.88Moderate Buy$266.31189.16% UpsideSMLRSemler Scientific 2.75Moderate Buy$75.33270.55% UpsideCurrent Analyst Ratings BreakdownLatest SMLR and MSTR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/7/2026MSTRStrategy BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageHold ➝ Overweight$130.007/7/2026MSTRStrategy BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy7/7/2026MSTRStrategy MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$265.00 ➝ $213.007/6/2026MSTRStrategy Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold6/30/2026MSTRStrategy Credit Suisse GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$250.006/30/2026MSTRStrategy CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$260.00 ➝ $136.006/30/2026MSTRStrategy BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$350.00 ➝ $250.006/30/2026MSTRStrategy TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$400.00 ➝ $260.006/30/2026MSTRStrategy Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$163.00 ➝ $130.006/24/2026MSTRStrategy Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)(Data available from 7/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMSTRStrategy$477.23M67.63N/AN/A$141.39 per share0.65SMLRSemler Scientific$36.96M8.41$4.48 per share4.54$24.90 per share0.82Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMSTRStrategy-$3.85B-$40.16N/A1.23N/A-2,482.01%-26.97%-19.15%7/30/2026 (Estimated)SMLRSemler Scientific$40.90M$2.787.31N/AN/A130.80%34.21%25.58%N/ALatest SMLR and MSTR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2026Q2 2026MSTRStrategy$0.7850N/AN/AN/A$121.88 millionN/A5/5/2026Q1 2026MSTRStrategy-$0.8620-$38.25-$37.3880-$38.25$120.75 million$124.30 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthMSTRStrategyN/AN/AN/AN/AN/ASMLRSemler ScientificN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMSTRStrategy0.226.056.05SMLRSemler Scientific0.211.971.95Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMSTRStrategy59.84%SMLRSemler Scientific49.37%Insider OwnershipCompanyInsider OwnershipMSTRStrategy6.49%SMLRSemler Scientific16.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMSTRStrategy1,539350.45 million327.70 millionOptionableSMLRSemler Scientific12015.29 million12.78 millionNot OptionableSMLR and MSTR HeadlinesRecent News About These CompaniesBitcoin treasury firm Strive raises $225 million to pay off loans, buy more bitcoinJanuary 30, 2026 | finance.yahoo.comKuehn Law Encourages Investors of Semler Scientific to Contact Law FirmJanuary 22, 2026 | newsfilecorp.comNSemler Scientific Closes Merger and Delisting with StriveJanuary 18, 2026 | theglobeandmail.comVivek Ramaswamy-backed Strive and Semler stocks rebound on Bitcoin recovery after reverse split shockJanuary 14, 2026 | msn.comASST and SMLR Stocks Drop as Strive Completes Acquisition of Bitcoin Treasury Firm SemlerJanuary 13, 2026 | coingape.comCWhy Semler Scientific, Inc.’s (SMLR) Stock Is Up 5.69%January 13, 2026 | aaii.comASemler outperforms crypto equities while Bitcoin slips below $91,000January 8, 2026 | msn.comWhy Semler Scientific, Inc.’s (SMLR) Stock Is Up 5.49%January 3, 2026 | aaii.comAASST Stock Performance Comes Into Question Amid Semler Scientific and Strive Merger ProspectsDecember 30, 2025 | finance.yahoo.comWhy Semler Scientific, Inc.’s (SMLR) Stock Is Up 6.91%December 16, 2025 | aaii.comASemler Scientific Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Semler Scientific, Inc. - SMLRDecember 12, 2025 | prnewswire.comStrive Starts $500M Preferred Stock 'At-The-Market' Program for Bitcoin PurchasesDecember 10, 2025 | finance.yahoo.comSMLR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Merger of Semler Scientific With Strive Asset ManagementDecember 9, 2025 | globenewswire.comSemler Scientific (SMLR) price target decreased by 12.83% to 66.98December 6, 2025 | msn.comOpendoor Bull Eric Jackson Is Launching A New Product To Make The Most Of Crypto Treasury FirmsNovember 24, 2025 | msn.comMaxim Group Keeps Their Buy Rating on Semler Scientific (SMLR)November 21, 2025 | theglobeandmail.comSemler Scientific CEO files to sell up to $30M sharesNovember 18, 2025 | finance.yahoo.comSemler Scientific Announces Merger with Strive, Inc.November 10, 2025 | msn.comHow Might Semler Scientific's (SMLR) Leadership Transition Shape Perceptions of Management Credibility?October 29, 2025 | finance.yahoo.comSemler Scientific® to Release Third Quarter 2025 Financial ResultsOctober 28, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesMission Control: Floating In SpaceX's Record-Breaking OrbitBy Jeffrey Neal Johnson | June 15, 2026Gravity Check: Houston, SpaceX Has a Valuation ProblemBy Jeffrey Neal Johnson | June 16, 20265 Tech Stocks to Buy on the July PullbackBy Thomas Hughes | June 29, 2026The Oil Trade May Not Be Over: 3 Energy Stocks to WatchBy Thomas Hughes | June 21, 2026Strategy’s Bitcoin Rally Has a Hidden EngineBy Jeffrey Neal Johnson | June 16, 2026SMLR and MSTR Company DescriptionsStrategy NASDAQ:MSTR$92.10 -2.54 (-2.68%) Closing price 04:00 PM EasternExtended Trading$91.85 -0.25 (-0.27%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Strategy Incorporated, formerly known as MicroStrategy, provides artificial intelligence-powered enterprise analytics software and services in the United States, Europe, the Middle East, Africa, and internationally. It offers Strategy ONE, a platform that allows non-technical users to access novel and actionable insights for decision-making, and Strategy Cloud for Government, which provides always-on threat monitoring designed to meet the strict technical and regulatory standards of governments and financial institutions. The company also delivers Strategy Support, helping customers achieve system availability and usage goals through responsive troubleshooting; Strategy Consulting, offering architecture and implementation services; and Strategy Education, which includes free and paid learning options. In addition, the company is actively involved in Bitcoin development. The company offers its services through direct sales force and channel partners. It serves the U.S. government, state and local governments, and government agencies, as well as a range of industries, including retail, banking, technology, manufacturing, insurance, consulting, healthcare, telecommunications, and the public sector. The company was incorporated in 1989 and is headquartered in Tysons Corner, Virginia.Semler Scientific NASDAQ:SMLRSemler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The SK Hynix IPO and 2027’s AI Memory Squeeze Why Welltower's Growth Story Might Outrun Its Rich Valuation Why Micron Is Doubling Down While the HBM Shortage Persists AMD's 5C Deal Positions It as a Direct NVIDIA Rival China's Helium Ban Could Reshape the AI Supply Chain The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions Analysts See Major Upside for These 5 Stocks One Short- and One Long-Term ETF for Quantum Computing Bulls Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
